Author

Eva Teufel

Observed names: E. Teufel, Teufel, Eva

Observed institutions: University of Würzburg, Universitätsklinikum Würzburg, University of Roehampton

ORCID: 0000-0002-3160-0434

Observed ORCID: 0000-0002-3160-0434

OpenAlex ID: A5075518146

CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement

2019 · Matteo Claudio Da Vià, Antonio Giovanni Solimando, et al. · The Oncologist · 58

PDF

Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia

2021 · Andoni Garitano-Trojaola, Ana Sancho, et al. · Communications Biology · 26

PDF

Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma

2022 · Larissa Haertle, Santiago Barrio, et al. · Clinical Cancer Research · 20

High-dose carfilzomib achieves superior anti-tumor activity over low-dose and recaptures response in relapsed/refractory multiple myeloma resistant to lowdose carfilzomib by co-inhibiting the β2 and β1 subunits of the proteasome complex

2023 · Xiang Zhou, Andrej Besse, et al. · Haematologica · 11

Bortezomib induced peripheral neuropathy and single nucleotide polymorphisms in PKNOX1

2023 · Xiang Zhou, Seungbin Han, et al. · Biomarker Research · 9

PDF

Parallel Evolution of Multiple PSMB5 mutations in a Myeloma Patient Treated with Bortezomib

2016 · Santiago Barrio, Thorsten Stühmer, et al. · Blood · 9

Functional Characterization of GPRC5D alteration and Its Impact on Talquetamab Resistance in Relapsed/ Refractory Multiple Myeloma

2023 · Seungbin Han, Umair Munawar, et al. · Blood · 8

Advanced Risk Stratification in Multiple Myeloma Beyond Traditional FISH: The First Prospective Real-World Evidence for SKY92 Gene Expression Profiling

2022 · Xiang Zhou, Annika Hofmann, et al. · Blood · 5

Erratum to: Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma

2024 · Umair Munawar, Johanna Theuersbacher, et al. · Haematologica · 4

PDF

Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma

2024 · Umair Munawar, Johanna Theuersbacher, et al. · Haematologica · 4

PDF

CIC-Mutation As a Potential Molecular Mechanism of Acquired Resistance to Combined BRAF/MEK Inhibition in CNS Multiple Myeloma

2018 · Matteo Claudio Da Via', Antonio Giovanni Solimando, et al. · Blood · 4

Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma

2023 · Umair Munawar, Xiang Zhou, et al. · Communications Biology · 3

PDF

Secondary Genetic Events Impact the Expression of Key Immunotargets on the Surface of Multiple Myeloma Cells

2023 · Umair Munawar, Patrick Eiring, et al. · Blood · 3

PDF

Differential CD38 Expression on Daratumumab-Naïve Vs. Resistant Multiple Myeloma - a Direct Stochastic Optical Reconstruction Microscopy ( dSTORM) Analysis in 53 Patients

2023 · Maximilian J Steinhardt, Patrick Eiring, et al. · Blood · 3

P52 Risk Stratification Combining Sky92 Gene Expression Profiling and Traditional Fish in Multiple Myeloma: the First Prospective Evidence in the R2-iss Era

2023 · X. Zhou, A. Hofmann, et al. · HemaSphere · 1

P44 Detection of Soluble Bcma in Tears of Mm Patients Treated With Belantamab Mafodotin

2023 · U. Munawar, J. Theuersbacher, et al. · HemaSphere · 1

Impaired Death Receptor Signaling Mediates Cross-Resistance to Immunotherapy in MM

2022 · Umair Munawar, Xiang Zhou, et al. · Blood · 1

Multiomic Analysis of CD38 Expression Levels in 209 Untreated and Daratumumab-Resistant Patients

2022 · Max Johannes Steinhardt, Patrick Eiring, et al. · Blood · 1

RAC1 Inhibitor EHT1864 and Venetoclax Overcome Midostaurin Resistance in Acute Myeloid Leukemia

2019 · Andoni Garitano-Trojaola, Ana Sancho, et al. · Blood · 1

Supplementary Figure 4 from Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma